| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 279,913 | 233,957 | 217,529 | | Cost of Revenue | 212,032 | 174,809 | 162,647 | | | Gross Profit | 67,881 | 59,148 | 54,882 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 21,487 | 18,003 | 16,580 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 46,394 | 41,145 | 38,302 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 507 | 1,079 | 535 | | Earnings Before Interest And Taxes | 46,901 | 42,224 | 38,837 | | Interest Expense |
-
|
-
| 2 | | Income Before Tax | 46,901 | 42,224 | 38,835 | | Income Tax Expense | 16,131 | 14,422 | 13,394 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,770 | 27,802 | 25,441 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 30,770 | 27,802 | 25,441 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,770 | $27,802 | $25,441 |
|
1.48% Nasdaq 
Income Statement
